Key highlights

  • Wesfarmers reported FY26 Revenue of $47,274 million, up 3.4%, and NPAT of $2,874 million, up 8.3% excluding prior-year significant items, in its 27 August 2026 release.
  • EBIT was $4,493 million, and the full-year ordinary Dividend was 222 cents, up 7.8%, fully franked.
  • Spodumene concentrate production was 209kt, above guidance, while the lithium refinery ramp-up was affected by odour issues.

Wesfarmers Ltd (ASX:WES) shares closed at $79.86, up 0.35%, on 21 October 2026. The S&P/ASX 200 Consumer Discretionary [XDJ] index closed at 3,741.90, up 0.34% (12.50 points), while the S&P/ASX 200 [XJO] finished at 8,831.30, up 0.16%, and the All Ordinaries at 8,956.60, up 0.14%, as at 5:00 pm GMT+11. Wesfarmers is a diversified Australian group including Bunnings, Kmart, Officeworks, health and chemicals, energy and fertilisers businesses.

What Wesfarmers does

Wesfarmers Limited owns Bunnings Group, Kmart Group (Kmart, Target and Anko), Officeworks, Wesfarmers Health including Priceline Pharmacy, and Wesfarmers Chemicals, Energy and Fertilisers (WesCEF), which includes a lithium business.

FY26 financial results

In an ASX release dated 27 August 2026, Wesfarmers reported revenue of $47,274 million, up 3.4%, EBIT of $4,493 million, up 0.6% (up 7.3% excluding prior-year significant items), and NPAT of $2,874 million, down 1.8% statutory and up 8.3% excluding prior-year significant items. Basic EPS was 253.4 cents. Operating Cash Flow was $4,272 million, down 6.5%. The full-year ordinary dividend was 222 cents, up 7.8%, fully franked. There were no significant items in FY26; FY25 significant items of $279 million related to the Coregas sale, the BPI property structure and Catch.

Divisions

The release said Bunnings, Kmart Group and WesCEF were the largest Earnings contributors. Bunnings and Kmart earnings were supported by everyday low prices, while WesCEF earnings were affected by the timing of higher ammonia prices linked to the Middle East conflict, offset by operational performance and an improved lithium contribution. Spodumene concentrate production was 209kt, above guidance and nameplate capacity, and the lithium refinery ramp-up was affected by intermittent odour issues, with mitigation measures begun late in FY26. Officeworks earnings reflected one-off transformation costs, and Wesfarmers Health delivered higher earnings.

Sector context

Consumer discretionary companies depend on household spending, travel, leisure and housing activity, and they are tracked through the S&P/ASX 200 Consumer Discretionary index, which closed at 3,741.90, up 0.34%, on 21 October 2026 alongside a 0.16% rise in the S&P/ASX 200 to 8,831.30. Wesfarmers’ divisions range from home improvement and discount retail to chemicals and lithium, so results reflect household spending, housing activity and Commodity prices.

Risks and uncertainties

Operating cash flow was lower, WesCEF earnings were affected by ammonia price timing, and the lithium refinery’s ramp-up has faced odour issues. Officeworks is in transformation. Cost-of-living pressures on households, commodity prices and housing activity can affect outcomes.

Catalysts to watch

Items to watch include the lithium refinery ramp-up, Officeworks transformation progress, the first-half trading update and the AGM.

Final word

Wesfarmers’ 27 August 2026 release recorded higher Underlying Profit and dividend, with lower operating cash flow. Later updates will show division trends.